---
schema_version: "secwatch.filing_event.v1"
accession: "0001040130-23-000011"
form_type: "8-K"
ticker: "PETS"
cik: "0001040130"
company_name: "PETMED EXPRESS INC"
filed_at: "2023-02-06T23:59:59+00:00"
generated_at: "2026-06-19T23:43:09.380451+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# PetMed Express reports Q3 net loss of $19K; revenue down 3% to $58.9M; declares $0.30 dividend

## Summary
- Net sales $58.9M (down 3% YoY); net loss $19K vs net income $4.3M prior year.
- Adjusted diluted EPS $0.02; Adjusted EBITDA $2.7M, down 64% from $7.6M.
- New customers increased 9% YoY, first increase in 10 quarters.
- Board declares $0.30 per share quarterly dividend, payable Feb 27, 2023 to holders of record Feb 20.
- Evaluating sales tax contingencies that could have material effect on results.

## SEC filing metadata
- accession: 0001040130-23-000011
- form_type: 8-K
- ticker: PETS
- cik: 0001040130
- company_name: PETMED EXPRESS INC
- filed_at: 2023-02-06T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1040130/000104013023000011/0001040130-23-000011-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1040130/000104013023000011/pets-20230206.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001040130-23-000011
- JSON: https://secwatch.observer/filing/0001040130-23-000011.json
- Plain text: https://secwatch.observer/filing/0001040130-23-000011.txt

## Key facts
- Earnings Releases
  PETMED EXPRESS INC reported third quarter ended December 31, 2022 results: revenue $58.9 million, net income $19.0 thousand, EPS $(0.00) diluted earnings per share.
  - Period: third quarter ended December 31, 2022
  - Revenue: $58.9 million
  - Net income: $19.0 thousand
  - EPS: $(0.00) diluted earnings per share
  - Result: reported results
  source text: Expert TM , today announced its financial results for its third quarter ended December 31, 2022. Quarterly Highlights • Net sales for the quarter ended December 31, 2022, were $58.9 million, compared to $60.7 million for third quarter in the prior year, a decrease of 3.0%. • PetMeds® reports new customers increased 9% year over year for the quarter ended December
  evidence_url: https://www.sec.gov/Archives/edgar/data/1040130/000104013023000011/0001040130-23-000011-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.